MPN
Advertisement
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Not all patients with polycythemia vera meet the WHO diagnostic criteria for hematocrit and hemoglobin values.
The study's authors presented the data at the 15th International Congress on Myeloproliferative Neoplasms.
A study presented at the 15th International Congress on MPNs synthesized existing literature to evaluate the association.
With the involvement of clinical nurse specialists, the average triage response time was within the same day.
Researchers examined the natural history, clinical characteristics, and outcomes of veterans with MPNs.
Limited diagnostic resources, such as EPO level tests, can result in late or misdiagnosis and increased health care costs.
The average cost of hospitalization for a TE was $4000-9000 higher than for generally medically ill patients.
Investigators noted improved spleen size and blood parameters in addition to improvement in PV symptoms.
Rusfertide improved response maintenance and reduced the need for therapeutic phlebotomy.
Overexpression of the JAK2 and MPL genes in mRNA was observed in an aspirin-resistant cohort with MPL.
Adolescents and young adults in Japan may have benefitted from earlier, health insurance-covered screening.
A small percentage of patients with PV had high platelet and white blood cell counts, but many had elevated hematocrit.
While physicians reported frequent screening and good communication, patients in one study disagreed.
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Patients with MPN who had an AMI are analyzed for risk of additional major adverse cardiovascular events and bleeding.
Do cytoreductive therapies affect quality of life for patients with MPN in different ways?
Researchers evaluated risk factors for ATEs and VTEs. Their scoring system performed better than the current standard.
The phase II study results are in. Researchers will now test rusfertide against placebo in a randomized clinical trial.
Researchers determined the incidence of TEAEs related to rusfertide in patients with PV.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.